The GDPR (General Data Protection Regulation) includes provisions that support the secondary use of existing health data for scientific research purposes, while also protecting the privacy and data protection rights of individuals.
One of the key ways that the GDPR supports the secondary use of health data for research is through the concept of “legitimate interests”. Article 6(1)(f) of the GDPR allows for the processing of personal data if it is necessary for the legitimate interests of the data controller or a third party, provided that those interests do not override the fundamental rights and freedoms of the data subject. Scientific research can be considered a legitimate interest, provided that appropriate safeguards are in place to protect individuals’ rights and freedoms.
In addition, the GDPR includes provisions that specifically address the use of health data for scientific research. For example, Article 9(2)(j) allows for the processing of special categories of personal data, such as health data, for scientific research purposes, provided that appropriate safeguards are in place.
The GDPR also requires that data controllers implement appropriate technical and organizational measures to ensure the security and confidentiality of personal data, including health data. This includes requirements for data pseudonymization and encryption, as well as procedures for data breach notification.
Overall, the GDPR strikes a balance between protecting individuals’ privacy and data protection rights, and supporting the important public interest in scientific research. By providing a framework for the responsible and transparent use of health data for research purposes, the GDPR can help to facilitate the development of new treatments and interventions that can improve public health outcomes.
Share this story...
Real World Evidence (RWE) 101 – ‘Interventional’ Clinical Trial vs Non-Interventional Study
RWE 101 - 'Interventional' Clinical Trial vs Non-Interventional Study Interventional Clinical Trial: In this type of study, researchers actively intervene by assigning participants to different groups, administering specific treatments, [...]
Real World Evidence (RWE) 101 – Are the terms ‘clinical study’ and ‘clinical trial’ synonymous in the context of non-interventional studies?
RWE 101 - Are the terms 'clinical study' and 'clinical trial' synonymous in the context of non-interventional studies? No, "clinical study" and "clinical trial" are not necessarily synonymous in [...]
Real World Evidence (RWE) 101 – The Importance of Regulatory Definitions
RWE 101 - The Importance of Regulatory Definitions "Words are powerful"Regulatory definitions are important in the context of real-world evidence (RWE) studies and real-world research for several reasons:[1] Consistency: [...]
Real World Evidence (RWE) 101 – Regulatory Compliance
RWE 101 - Regulatory Compliance Regulatory compliance in the context of real-world evidence (RWE) refers to ensuring that the generation and use of RWE for regulatory purposes [...]
Real World Evidence (RWE) 101 – Regulatory Intelligence
RWE 101 - Regulatory Intelligence In the context of real-world evidence (RWE) and real-world research (RWR), regulatory intelligence refers to the process of gathering, analyzing, and interpreting regulatory information [...]
Real World Evidence (RWE) 101 – Regulatory Science
RWE 101 - Regulatory Science Regulatory science is a field of study that involves the application of scientific methods, principles, and data to the development and evaluation of regulatory [...]







